Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Congress Considers Legislation to Secure Drug Supply Chain

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.
Jun 2, 2013

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.

Regulatory Roundup

May 2, 2013

FDA faces budget crunch; Supreme Court hears key cases

Regulatory Convergence Sought for Global Pharma Market

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
May 2, 2013

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.

Regulatory Roundup

Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.
Apr 2, 2013

Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.

Manufacturers Under Pressure to Manage Painkillers

Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.
Apr 2, 2013

Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.

Vaccine Innovation Yields New Products and Processes

Vaccine development is benefiting from manufacturing advances and support for global health.
Mar 2, 2013

Vaccine development is benefiting from manufacturing advances and support for global health.

GMP Compliance Becomes Prominent Enforcement Issue

Prosecutors and regulators challenge manufacturing quality failings likely to cause patient harm.
Feb 2, 2013

Prosecutors and regulators challenge manufacturing quality failings likely to cause patient harm.

Drug Quality at Center Stage for FDA and Manufacturers

Shortages and compounding disaster spur efforts to overhaul manufacturing oversight and stimulate industry improvements.
Jan 1, 2013

Shortages and compounding disaster spur efforts to overhaul manufacturing oversight and stimulate industry improvements.

Health Policy Challenges for Obama Administration

White House and Congress likely to struggle over funding for bio/pharmaceutical regulation.
Dec 2, 2012

White House and Congress likely to struggle over funding for bio/pharmaceutical regulation.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here